Researchers explains how their experience with the Zika virus, made possible with funding from FAPESP, helped them to cultured the SARS-CoV-2 coronavirus (image: Agência FAPESP)
New coronavirus is produced in Brazilian laboratory
April 08, 2020
Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have cultured the SARS-CoV-2 coronavirus in a laboratory. The virus that caused COVID-19 was isolated from the first two patients diagnosed with the disease in the city of São Paulo, at the Albert Einstein Jewish Hospital.
The viruses will be distributed to research groups and public and private clinical laboratories throughout Brazil to enhance their capacity to perform diagnostic tests and investigate how the disease spreads.
"Our aim in producing the coronavirus in the laboratory was precisely to have the virus for distribution throughout Brazil. We had the example of zika. When the zika outbreak happened in late 2015, we knew nothing about zika. We had no isolated viruses," Edison Luiz Durigon, professor at USP’s Institute of Biomedical Sciences, told Agência FAPESP.
"We produced large numbers of the virus and distributed them to labs in FAPESP’s network in São Paulo and also to the network of the Brazilian Ministry of Health. As a result the labs achieved very fast scientific progress. In three months we already had papers published in Nature and Science, for example. The same thing applies now to the coronavirus," Durigon said.
Watch bellow the full interview with professor Durigon (turn on the subtitles to English):
Republish
Republish
Agência FAPESP licenses news reports under Creative Commons license CC-BY-NC-ND so that they can be republished free of charge and in a straightforward manner by other digital media or by print media. The name of the author or reporter (when applied) must be cited, as must the source (Agência FAPESP). Using the button HTML below ensures compliance with the rules described in Agência FAPESP’s Digital Content Republication Policy.
